Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jiangsu Hansoh Pharmaceutical Group Co., Ltd

Latest From Jiangsu Hansoh Pharmaceutical Group Co., Ltd

VBP Pains Swell Prompting New China Strategy, Local Innovation Focus

As the rollout of volume-based procurement to more products brings more pain, drug makers are exploring different China strategies. One indicator, though, is clear - local innovation and distribution can’t be ignored anymore.

China Commercial

ESMO 23: Kelun/Merck, Hansoh ADCs Impress With Early Data In Breast Cancer

In new data from Chinese developers at ESMO, Kelun/Merck’s Trop2-targeting ADC SKB264 (MK-2870) appears ready to hog the limelight from Daiichi Sankyo/AstraZeneca’s Dato-DXd, while Hansoh’s B7-H4-targeting HS-20089 is coming to the fore against its global same-class competitors. There were also new clinical results for Mabwell/Hengrui’s Nectin-4-targeting 9MW2821 and HER2-targeting SHR-A1811.

China Clinical Trials

China Steps In To Help Relieve US Cancer Drug Shortages

At least one major Chinese supplier is being tapped to relieve a shortage of certain drugs in the US despite rising Beijing-Washington tensions, but China may be increasingly unwilling to co-operate amid its own shifting economic priorities, increasingly introspective policies and some shortages of its own. 

China Cancer

China’s Cancer Market Is Evolving Fast, Four Multinationals Dominate

In the Chinese pharmaceutical market, sales of anti-tumor drugs have been showing a steady growth trend in recent years as cancer patient numbers continue to rise.

Asia Pacific China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals